These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A mouse model of familial hypertrophic cardiomyopathy. Geisterfer-Lowrance AA; Christe M; Conner DA; Ingwall JS; Schoen FJ; Seidman CE; Seidman JG Science; 1996 May; 272(5262):731-4. PubMed ID: 8614836 [TBL] [Abstract][Full Text] [Related]
23. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy. Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637 [TBL] [Abstract][Full Text] [Related]
24. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Vikstrom KL; Factor SM; Leinwand LA Mol Med; 1996 Sep; 2(5):556-67. PubMed ID: 8898372 [TBL] [Abstract][Full Text] [Related]
25. Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathy. Khan RS; Chokshi A; Drosatos K; Jiang H; Yu S; Harris CR; Schulze PC; Homma S; Blaner WS; Shulman GI; Huang LS; Goldberg IJ J Cardiovasc Pharmacol; 2013 Apr; 61(4):345-54. PubMed ID: 23567901 [TBL] [Abstract][Full Text] [Related]
26. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. Fatkin D; Christe ME; Aristizabal O; McConnell BK; Srinivasan S; Schoen FJ; Seidman CE; Turnbull DH; Seidman JG J Clin Invest; 1999 Jan; 103(1):147-53. PubMed ID: 9884344 [TBL] [Abstract][Full Text] [Related]
27. Age-related changes in familial hypertrophic cardiomyopathy phenotype in transgenic mice and humans. Luo HC; Pozios I; Vakrou S; Sorensen L; Abraham RM; Abraham T J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):634-639. PubMed ID: 25318870 [TBL] [Abstract][Full Text] [Related]
28. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. Freeman K; Colon-Rivera C; Olsson MC; Moore RL; Weinberger HD; Grupp IL; Vikstrom KL; Iaccarino G; Koch WJ; Leinwand LA Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H151-9. PubMed ID: 11123229 [TBL] [Abstract][Full Text] [Related]
29. Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Goldspink PH; Montgomery DE; Walker LA; Urboniene D; McKinney RD; Geenen DL; Solaro RJ; Buttrick PM Circ Res; 2004 Aug; 95(4):424-32. PubMed ID: 15242976 [TBL] [Abstract][Full Text] [Related]
30. Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy. Hongo M; Ryoke T; Schoenfeld J; Hunter J; Dalton N; Clark R; Lowe D; Chien K; Ross J Basic Res Cardiol; 2000 Dec; 95(6):431-41. PubMed ID: 11192363 [TBL] [Abstract][Full Text] [Related]
31. The functional effect of dilated cardiomyopathy mutation (R144W) in mouse cardiac troponin T is differently affected by α- and β-myosin heavy chain isoforms. Gollapudi SK; Tardiff JC; Chandra M Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H884-93. PubMed ID: 25681424 [TBL] [Abstract][Full Text] [Related]
32. Development of dilated cardiomyopathy in Bmal1-deficient mice. Lefta M; Campbell KS; Feng HZ; Jin JP; Esser KA Am J Physiol Heart Circ Physiol; 2012 Aug; 303(4):H475-85. PubMed ID: 22707558 [TBL] [Abstract][Full Text] [Related]
33. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. Sah VP; Minamisawa S; Tam SP; Wu TH; Dorn GW; Ross J; Chien KR; Brown JH J Clin Invest; 1999 Jun; 103(12):1627-34. PubMed ID: 10377168 [TBL] [Abstract][Full Text] [Related]
34. Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified Yuan CC; Kazmierczak K; Liang J; Zhou Z; Yadav S; Gomes AV; Irving TC; Szczesna-Cordary D Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2338-E2347. PubMed ID: 29463717 [TBL] [Abstract][Full Text] [Related]
35. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849 [TBL] [Abstract][Full Text] [Related]
36. Molecular basis of hypertrophic and dilated cardiomyopathy. Marian AJ; Roberts R Tex Heart Inst J; 1994; 21(1):6-15. PubMed ID: 8180512 [TBL] [Abstract][Full Text] [Related]